UL Solutions Inc.

ULS ·Healthcare, Diagnostics & Research, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $816.0M $758.0M $789.0M $783.0M $776.0M $705.0M $739.0M $731.0M
Cost of Revenue $399.0M $377.0M $395.0M $389.0M $394.0M $365.0M $390.0M $373.0M
Gross Profit $417.0M $381.0M $394.0M $394.0M $382.0M $340.0M $349.0M $358.0M
Gross Margin 51.1% 50.3% 49.9% 50.3% 49.2% 48.2% 47.2% 49.0%
Operating Expenses
Research & Development
SG&A Expense $267.0M $243.0M $239.0M $238.0M $244.0M $232.0M $235.0M $228.0M
Operating Income $150.0M $138.0M $118.0M $156.0M $139.0M $109.0M $115.0M $130.0M
Operating Margin 18.4% 18.2% 15.0% 19.9% 17.9% 15.5% 15.6% 17.8%
Interest Expense
Pretax Income $338.0M $129.0M $105.0M $146.0M $125.0M $94.0M $92.0M $116.0M
Income Tax Expense $84.0M $32.0M $34.0M $40.0M $28.0M $23.0M $7.0M $22.0M
Net Income $246.0M $92.0M $67.0M $100.0M $91.0M $67.0M $81.0M $88.0M
Net Margin 30.1% 12.1% 8.5% 12.8% 11.7% 9.5% 11.0% 12.0%
EPS (Basic) $1.22 $0.46 $0.33 $0.50 $0.45 $0.34 $0.40 $0.44
EPS (Diluted) $1.21 $0.45 $0.33 $0.49 $0.45 $0.33 $0.40 $0.44
Shares Outstanding (Basic) 202.0M 201.0M 201.0M 201.0M 201.0M 200.0M 200.0M 200.0M
Shares Outstanding (Diluted) 204.0M 204.0M 203.0M 203.0M 203.0M 203.0M 201.0M 202.0M
Dividends Per Share $0.15 $0.15 $0.13 $0.13 $0.13 $0.13 $0.13 $0.13
← Newer Page 1 of 2 Older →